Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(38%)

Phase Distribution

Ph phase_3
3
38%
Ph not_applicable
1
13%
Ph phase_2
4
50%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
4(50.0%)
Phase 3Large-scale testing
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Terminated(3)
Other(5)

Detailed Status

unknown5
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (50.0%)
Phase 33 (37.5%)
N/A1 (12.5%)

Trials by Status

terminated338%
unknown563%

Recent Activity

0 active trials
Showing 5 of 8
terminatedphase_3

Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer

NCT03042169
terminatednot_applicable

Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable Factor

NCT02969122
unknownphase_2

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

NCT05353582
unknownphase_2

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

NCT02934828
unknownphase_3

Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis

NCT02912052
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT03042169Phase 3

Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer

Terminated
NCT02969122Not Applicable

Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable Factor

Terminated
NCT05353582Phase 2

Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases

Unknown
NCT02934828Phase 2

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Unknown
NCT02912052Phase 3

Perioperative Chemotherapy VS Postoperative Chemotherapy for the Treatment of Colon Cancer With Resectable Liver Metastasis

Unknown
NCT02882269Phase 2

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

Unknown
NCT01189227Phase 3

Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery

Terminated
NCT01787539Phase 2

The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8